GMED · Globus Medical Inc
United States · RS rating 47 · As of 2026-10-14
| Price | 76.31 USD |
|---|---|
| 1-day change | -0.0% |
| RS rating (overall / 1M / 3M / 12M) | 47 / 82 / 42 / 83 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 35 / 37 / 34 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +17.1% |
| Sales growth Q/Q | +7.5% |
| Distance from 52-week high | +21.2% |
| Market cap (USD) | $12.8B |